Powered by

Home Funding News Aragen Raises $100 Mn From Quadria Capital

Aragen Raises $100 Mn From Quadria Capital

Aragen Life Science, a global research and manufacturing firm, received a $100 million investment from Quadria Capital, a healthcare-focused private equity fund. 

By Jitendra swami
New Update
Aragen Raises $100 Mn From Quadria Capital

Aragen Life Science, a global research and manufacturing firm, received a $100 million investment from Quadria Capital, a healthcare-focused private equity fund. 

Quadria now holds a minority stake, valuing Aragen at around $1.4 billion. Quadria's investment makes it the second strategic investor in Aragen, alongside Goldman Sachs.

The company plans to use fresh funds to help expand its facilities and services to meet the growing demand for outsourcing from innovators in the US and Europe.

Read also - Swiggy Partners with Blue Tokai to Offer 15-Minute Coffee Delivery Through SNACC

Manni Kantipudi, CEO of Aragen Life Science, said, “We are delighted to welcome Quadria to Aragen. This investment marks a pivotal moment as we scale to meet the needs of a rapidly evolving market. Our expanded capabilities will allow us to support the rising demand for integrated discovery and manufacturing services, and, most importantly, help our customers accelerate their programs to market faster and more efficiently."

Dr. Amit Varma, Managing Partner and co-Founder of Quadria Capital, said, “The pharmaceutical outsourcing sector presents compelling growth opportunities, especially in the current environment which is driven by global supply chain reorganization. Aragen’s impressive track record, customer-centric approach, and commitment to innovation make it an ideal partner for global pharmaceutical companies. We look forward to partnering with them and supporting their next phase of growth.”

About Aragen Life Science

Aragen is tapping into the growing outsourcing market as Western companies diversify supply chains to avoid global disruptions. It offers services from discovery to manufacturing for small molecules and biologics, serving over 400 clients, including 15 of the top 20 pharma companies.

Advertisment

Want to go deeper into the world of startups and entrepreneurship? Check out these categories on VIESTORIES:

Startup Funding and StoriesDiscover Funding Trends and Stories Shaping Indian Startups.

Startup Funding NewsYour Gateway to Every Funding Update.

Latest Startup NewsStay updated with the latest startup news and trends. Your go-to source for startup ecosystem updates.

Startup StoriesDiscover inspiring tales of startups overcoming challenges and achieving success.